GHDX Latest News, Press Relases and Analysis

All

Press Releases

6 years ago - By: Zacks Investment Research

Why the Earnings Surprise Streak Could Continue for Genomic Health (GHDX)

6 years ago - By: EXACT SCIENCES CORP - Mentions: EXAS

Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

6 years ago - By: Genomic Health, Inc. - Mentions: EXAS

Genomic Health Stockholders Approve Proposed Acquisition by Exact Sciences

6 years ago - By: Analyst Ratings - Mentions: RARE JPM

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ultragenyx Pharmaceutical (NASDAQ: RARE) and Genomic Health (NASDAQ: GHDX)

6 years ago - By: Seeking Alpha - Mentions: SHEN

Shentel set to join SmallCap 600

6 years ago - By: Seeking Alpha

Genomic Health reported EPS beat of $0.10

6 years ago - By: StockNews.com - Mentions: PCG IPHI AXE TENB ...

Best & Worst Performing Mid Cap Stocks for October 30, 2019

6 years ago - By: Seeking Alpha - Mentions: MAT GDOT PSMT IPHI ...

ENPH, MAT, CHRW and AJRD among after hour movers

6 years ago - By: Zacks Investment Research

Genomic Health (GHDX) Earnings Expected to Grow: Should You Buy?

6 years ago - By: Zacks Investment Research - Mentions: AMGN GILD EXAS

Exact Sciences (EXAS) to Post Q3 Earnings: What's in Store?

6 years ago - By: Benzinga - Mentions: AKRX BBBY GLUU GPOR ...

25 Stocks Moving in Tuesday's Pre-Market Session

6 years ago - By: The Motley Fool - Mentions: NEO NVTA

Here's Why Genetic Testing Stocks Tumbled in September

6 years ago - By: InvestorPlace - Mentions: BMY CELG EXAC BLUE ...

3 Cancer-Fighting Drug Stocks to Buy Right Now

6 years ago - By: Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Genomic Health, Inc. (GHDX)

6 years ago - By: Genomic Health, Inc.

New TAILORx Data, Published Today in JAMA Oncology, Add to Strong Evidence Base Reinforcing Unique Ability of Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy Treatment

6 years ago - By: Zacks Investment Research - Mentions: TRHC ISRG DXCM TDOC

Stocks & ETF to Invest in Healthcare Robotics and Innovation

6 years ago - By: Zacks Investment Research - Mentions: PFE EXAS GH

Exact Sciences Gets FDA Nod for Label Expansion of Cologuard

6 years ago - By: Zacks Investment Research - Mentions: TRHC ISRG DXCM TDOC

Stocks & ETF to Invest in Healthcare Robotics and Innovation

6 years ago - By: InvestorPlace - Mentions: GOOG ULTA CPRT MSFT ...

10 Excellent Stocks to Watch for 2020 and Beyond

6 years ago - By: Halper Sadeh LLP - Mentions: NCI TYPE

SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - GHDX, NCI, TYPE

6 years ago - By: Halper Sadeh LLP - Mentions: MCRN SRCI

SHAREHOLDER ALERT: HALPER SADEH LLP CONTINUES TO INVESTIGATE WHETHER THE SALE OF THESE COMPANIES IS FAIR TO SHAREHOLDERS - MCRN, SRCI, GHDX

6 years ago - By: Zacks Investment Research

Why Is Genomic Health (GHDX) Down 0.5% Since Last Earnings Report?

6 years ago - By: Zacks Investment Research - Mentions: BAX NUVA MDT

Genomic Health Test to Guide Chemo Per New Breast Cancer Rule

6 years ago - By: Genomic Health, Inc.

New St. Gallen International Breast Cancer Guidelines Recommend Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy for Node-negative and Node-positive Early-stage Breast Cancer

6 years ago - By: The Motley Fool - Mentions: NVS EXAS

GENOMIC HEALTH INC (GHDX) Stock News

GHDX Latest News, Press Relases and Analysis

Why the Earnings Surprise Streak Could Continue for Genomic Health (GHDX)

Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

Genomic Health Stockholders Approve Proposed Acquisition by Exact Sciences

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ultragenyx Pharmaceutical (NASDAQ: RARE) and Genomic Health (NASDAQ: GHDX)

Shentel set to join SmallCap 600

Genomic Health reported EPS beat of $0.10

Best & Worst Performing Mid Cap Stocks for October 30, 2019

ENPH, MAT, CHRW and AJRD among after hour movers

Genomic Health (GHDX) Earnings Expected to Grow: Should You Buy?

Exact Sciences (EXAS) to Post Q3 Earnings: What's in Store?

25 Stocks Moving in Tuesday's Pre-Market Session

Here's Why Genetic Testing Stocks Tumbled in September

3 Cancer-Fighting Drug Stocks to Buy Right Now

Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Genomic Health, Inc. (GHDX)

New TAILORx Data, Published Today in JAMA Oncology, Add to Strong Evidence Base Reinforcing Unique Ability of Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy Treatment

Stocks & ETF to Invest in Healthcare Robotics and Innovation

Exact Sciences Gets FDA Nod for Label Expansion of Cologuard

Stocks & ETF to Invest in Healthcare Robotics and Innovation

10 Excellent Stocks to Watch for 2020 and Beyond

SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - GHDX, NCI, TYPE

SHAREHOLDER ALERT: HALPER SADEH LLP CONTINUES TO INVESTIGATE WHETHER THE SALE OF THESE COMPANIES IS FAIR TO SHAREHOLDERS - MCRN, SRCI, GHDX

Why Is Genomic Health (GHDX) Down 0.5% Since Last Earnings Report?

Genomic Health Test to Guide Chemo Per New Breast Cancer Rule

New St. Gallen International Breast Cancer Guidelines Recommend Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy for Node-negative and Node-positive Early-stage Breast Cancer

A Breach of Trust? Here's Why the FDA's Taking Aim at Novartis' AveXis